Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

Eribulin BOS 0.5 mg/ml Solution for injection 2ml Vial

In stock
Only 1 left
SKU
10331014219

Eribulin BOS 0.5 mg/ml Solution for injection is a chemotherapy drug used to treat specific advanced cancers, including metastatic breast cancer and liposarcoma. It works by inhibiting cancer cell growth and is administered intravenously by healthcare professionals under strict medical supervision. This potent medication requires careful monitoring for potential side effects.

Product Overview

Eribulin BOS 0.5 mg/ml Solution for injection is a highly effective chemotherapy medication.
It is specifically designed for the treatment of certain types of advanced cancers.
This solution is administered intravenously by healthcare professionals.

Benefits of Use

  • Effective in treating metastatic breast cancer in patients who have received at least two prior chemotherapy regimens for metastatic disease.
  • Indicated for the treatment of unresectable or metastatic liposarcoma in patients who have received prior chemotherapy for advanced or metastatic disease.
  • Works by inhibiting microtubule dynamics, leading to cell cycle arrest and apoptosis in cancer cells.
  • Provides a targeted approach to disrupt cancer cell growth and division.

How to Use

  1. Eribulin BOS is administered by a qualified healthcare professional intravenously (into a vein).
  2. The dosage will be calculated based on the patient's body surface area and will be determined by the treating physician.
  3. It is typically given over 2 to 5 minutes on specific days of a 21-day cycle.
  4. Patients should adhere strictly to their prescribed treatment schedule.

Caution & Warnings

  • May cause serious side effects, including neutropenia (low white blood cell count) and peripheral neuropathy (nerv.e damage).
  • Fatigue, nausea, alopecia (hair loss), constipation, and vomiting are common side effects.
  • Patients should be monitored closely for signs of infection due to neutropenia.
  • Inform your doctor if you experience any numbness, tingling, or weakness in your hands or feet.
  • Not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant.
  • Discuss all current medications, including over-the-counter drugs and herbal supplements, with your doctor to avoid potential drug interactions.

Ingredients

  • Active ingredient: Eribulin mesylate (equivalent to 0.5 mg/ml Eribulin)
  • Excipients: Ethanol, water for injection, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment).

Product Details

  • Brand: Eribulin BOS
  • Strength: 0.5 mg/ml
  • Volume: 2ml per vial
  • Form: Solution for injection
  • Manufacturer: Eisai (original developer of Eribulin)
More Information
Gtin 2906257635
Recommended Sale Price 1033.15
Is Wasfaty Product No
Brand Not Defined
Ingredient Name ERIBULIN MESILATE
SFDA Reg. No 2906257635
IBC 2906257635
Drug Type Prescription
Scientific Name Eribulin mesylate
Strength 0.5
Strength Unit mg/ml
Form Solution for injection
Admin Route Intravenous
Size 2
Size Unit ml
Package Types Vial
Package Size 2ml
Storage conditions Store in a refrigerator (2°C - 8°C). Do not freeze.
Refrigerator Storage Yes